PATENT CLAIM ANALYSIS

Application Number: 16031686
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "170000"]

Abstract:
Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

Claim (Index 35):
A unit dosage form of abiraterone acetate containing 125 mg of abiraterone acetate having a [D50] greater than 100 nm and less than 1200 nm, the unit dosage form further comprising a diluent, a wetting agent, a disintegrant, a lubricant, and one or both of an antioxidant and a sequestering agent,\n wherein the dissolution rate of the abiraterone acetate in the unit dosage form is such that when the unit dosage form is tested in 900 ml of pH 4.5 phosphate buffer with 0.12% sodium lauryl sulfate using USP Apparatus II at 75 rpm, at least 70% of the abiraterone acetate dissolves in between 5 and 15 minutes; and wherein a 500 mg dose, upon oral administration to a population of healthy male subjects in the fasted state, provides a mean blood plasma Cmax of 50-120 ng/ml and a mean blood plasma AUC(0-\u221e) of 240-650 h*ng/ml.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 95.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15645895', '15345410', '13776536', '14974108', '14810240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973912694226821
- 35 USC 102 Novelty (BERT): 0.6347123110265503
- Combined Prediction Score: 0.781123373583069
- Mean Citation Score: 438.725592
- Max Citation Score: 646.14996
- Similarity Product: 546.3780957480668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test